Athersys, Inc. - ATHX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: June 16, 2013

Athersys, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
ATHX	Nasdaq	2834	http://www.athersys.com/	1.62 0.00
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Athersys, Inc. ATHERSYS, INC / NEW Financials - May 21st, 2013 11:04 am Wider-Than-Expected Loss at Athersys - May 15th, 2013 7:30 am Athersys Management Discusses Q1 2013 Results - Earnings Call Transcript - May 14th, 2013 7:50 pm Athersys Reports First Quarter 2013 Results - May 14th, 2013 2:05 pm Elan in Royalty Deal with THRX - May 14th, 2013 2:00 pm Celgene Attains 52-Week High - May 14th, 2013 10:13 am Spectrum Pharma Reports 1Q Loss - May 14th, 2013 7:30 am ATHERSYS, INC / NEW Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib - May 14th, 2013 7:06 am Q1 2013 Athersys, Inc. Earnings Release - After Market Close - May 14th, 2013 5:07 am Glaxo/THRX's Breo Ellipta Gets FDA Nod - May 13th, 2013 3:20 pm Does Cell Therapy Hold The Key To Treating Stroke? - May 13th, 2013 8:51 am Medivation Loss Narrower Than Expected - May 13th, 2013 6:10 am Athersys: Here’s What Investors Need to Know Before Earnings - May 12th, 2013 4:04 pm Disappointing 1Q Earnings for IART - May 10th, 2013 8:25 am Dendreon Narrows 1Q Loss - May 10th, 2013 8:10 am Positive Data on Celgene's Apremilast - May 9th, 2013 1:30 pm Speculative Bio Stocks For Investors - May 8th, 2013 8:29 am Isis Initiates ISIS-STAT3 Study - May 7th, 2013 3:16 pm Safe Stem Cell Therapy for Healing Is Still a Strong Bet - May 7th, 2013 1:28 pm Earnings Miss at Perrigo - May 7th, 2013 10:10 am View All Current Headlines >>